Lymph node dissection for melanoma: where do we stand?

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Melanoma Management

• Publication date

  2017-03-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.2217/mmt-2016-0023PMID 30190904PMCID PMC6094624
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Safety and Feasibility of Minimally Invasive Inguinal Lymph Node Dissection in Patients With Melanoma (SAFE-MILND): Report of a Prospective Multi-institutional Trial

  2017cited by this paper
• Circulating Tumor Cells, DNA, and mRNA: Potential for Clinical Utility in Patients With Melanoma.

  2016cited by this paper
• Ultrasound of the sentinel node in melanoma patients: echo-free island is a discriminatory morphologic feature for node positivity

  2016cited by this paper
• Ultrasound-guided photoacoustic imaging for the selective detection of EGFR-expressing breast cancer and lymph node metastases

  2016cited by this paper
• Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial.

  2016cited by this paper
• Toward in vivo biopsy of melanoma based on photoacoustic and ultrasound dual imaging with an integrated detector.

  2016cited by this paper
• Circulating biomarkers in malignant melanoma.

  2015cited by this paper
• Clinical Impact of Preoperative Sentinel Lymph Node Imaging With SPECT/CT in the Management of Interscapular Malignant Melanoma.

  2015cited by this paper
• Handheld photoacoustic probe to detect both melanoma depth and volume at high speed in vivo

  2015cited by this paper
• Metastatic status of sentinel lymph nodes in melanoma determined noninvasively with multispectral optoacoustic imaging

  2015cited by this paper
• Clinical Usefulness of a Novel Freehand 3D Imaging Device for Radio-Guided Intraoperative Sentinel Lymph Node Detection in Malignant Melanoma

  2015cited by this paper
• Survival of SLNB-positive melanoma patients with and without complete lymph node dissection: A multicenter, randomized DECOG trial.

  2015cited by this paper
• Isolation of Circulating Melanoma Cells.

  2015cited by this paper
• Sentinel lymph node biopsy revisited: ultrasound-guided photoacoustic detection of micrometastases using molecularly targeted plasmonic nanosensors.

  2014cited by this paper
• International Multi-institutional Management and Outcome of Melanoma Patients with Positive Sentinel Lymph Nodes in More than One Nodal Basin

  2014cited by this paper
• Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma.

  2014cited by this paper
• Final trial report of sentinel-node biopsy versus nodal observation in melanoma.

  2014cited by this paper
• Ultrasound-guided fine needle aspiration cytology as an addendum to sentinel lymph node biopsy can perfect the staging strategy in melanoma patients.

  2014cited by this paper
• Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma

  2012cited by this paper
• Prognosis in patients with sentinel node‐positive melanoma without immediate completion lymph node dissection

  2012cited by this paper
• Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria.

  2011cited by this paper
• Positive Nonsentinel Node Status Predicts Mortality in Patients with Cutaneous Melanoma

  2008cited by this paper
• Sentinel Node Tumor Burden According to the Rotterdam Criteria Is the Most Important Prognostic Factor for Survival in Melanoma Patients: A Multicenter Study in 388 Patients With Positive Sentinel Nodes

  2008cited by this paper
• Complete Lymph Node Dissection for Sentinel Node-Positive Melanoma: Assessment of Practice Patterns in the United States

  2008cited by this paper
• Prognostic false-positivity of the sentinel node in melanoma

  2008cited by this paper
• Melanoma Patients with Positive Sentinel Nodes Who Did Not Undergo Completion Lymphadenectomy: A Multi-Institutional Study

  2006cited by this paper
• Sentinel-node biopsy or nodal observation in melanoma.

  2006cited by this paper
• Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative?

  2006cited by this paper
• The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement.

  2004cited by this paper
• Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial.

  2000cited by this paper
• Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm)

  2000cited by this paper
• Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group.

  1999cited by this paper
• Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme.

  1998cited by this paper
• The impact of ultrasound scanning in the staging and follow-up of patients with clinical stage I cutaneous melanoma.

  1997cited by this paper
• Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger.

  1996cited by this paper
• Selective lymphadenectomy: emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma.

  1993cited by this paper
• Technical details of intraoperative lymphatic mapping for early stage melanoma.

  1992cited by this paper
• Sonography versus palpation in the detection of regional lymph-node metastases in patients with malignant melanoma.

  1990cited by this paper
• Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities

  1982cited by this paper
• A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma.

  1979cited by this paper
• A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Preliminary results

  1978cited by this paper
• Biostatistical basis of elective node dissection for malignant melanoma.

  1977cited by this paper
• Results of regional lymph node dissection for melanoma.

  1974cited by this paper
• Should lymphadenectomy be discarded? I. Immunological considerations.

  1973cited by this paper
• Treatment of malignant melanoma: wide excision alone vs lymphadenectomy.

  1972cited by this paper
• Malignant melanoma: the problem of lymph-node metastases.

  1969cited by this paper
• The histogenesis and biologic behavior of primary human malignant melanomas of the skin.

  1969cited by this paper
• A study of 650 observed malignant melanomas in the South-West region.

  1968cited by this paper
• A study of 650 observed malignant melanomas in the South-West region.

  1968cited by this paper
• Malignant Melanoma: A Clinical Study of 427 Cases

  1965cited by this paper
• The role of regional node dissection in the treatment of malignant melanoma.

  1962cited by this paper
• Clinicopathological correlations in a series of 117 malignant melanomas of the skin of adults

  1958cited by this paper

• The Journey of Sentinel Lymph Node Biopsy in Cutaneous Melanoma: A Brief Narrative Review from Scalpel to Smart Tech

  2025cites this paper
• Sentinel lymph node biopsy for melanoma in the older population: A prospective analysis of outcomes

  2024cites this paper
• Establishment and Validation of Prognostic Nomograms for Nonmetastatic Melanoma of the Limbs—A SEER-Based Study

  2024cites this paper
• Lymphadenectomy in the treatment of sarcomas – indications and technique

  2024cites this paper
• Current Controversies in Melanoma Treatment

  2023cites this paper